Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan · Delayed Price · Currency is JPY 6,787.00
-148.00 (-2.13%)
Oct 27, 2025, 3:30 PM JST
Chugai Pharmaceutical Employees
Chugai Pharmaceutical had 5,026 employees as of December 31, 2024. The number of employees decreased by 2,578 or -33.90% compared to the previous year.
Employees
5,026
Change (1Y)
-2,578
Growth (1Y)
-33.90%
Revenue / Employee
241.49M JPY
Profits / Employee
79.02M JPY
Market Cap
11.19T
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5,026 | -2,578 | -33.90% |
| Dec 31, 2023 | 7,604 | -167 | -2.15% |
| Dec 31, 2022 | 7,771 | 107 | 1.40% |
| Dec 31, 2021 | 7,664 | 109 | 1.44% |
| Dec 31, 2020 | 7,555 | 161 | 2.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,455 |
| HOYA Corporation | 37,909 |
| Otsuka Holdings | 35,338 |
| Olympus | 29,297 |
| Daiichi Sankyo Company | 19,765 |
| M3, Inc. | 15,360 |
| Astellas Pharma | 13,643 |
| Eisai | 10,917 |
Chugai Pharmaceutical News
- 3 days ago - Chugai Pharmaceutical 9-month Net Income Rises - Nasdaq
- 7 days ago - Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
- 10 days ago - Rani Therapeutics surges on Chugai licensing deal, private placement - Seeking Alpha
- 10 days ago - Rani Teams Up With Chugai To Revolutionize Oral Drug Delivery For Rare Diseases - Benzinga
- 3 months ago - Chugai Pharmaceutical Co., Ltd. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Chugai Pharmaceutical reports Q2 results - Seeking Alpha
- 5 months ago - Biotech behind Eli Lilly obesity pill aims for new standard of care - Financial Times